Relay Therapeutics (RLAY) Treasury Shares (2019 - 2025)

Relay Therapeutics (RLAY) has 6 years of Treasury Shares data on file, last reported at $163606.0 in Q4 2025.

• On a quarterly basis, Treasury Shares fell 90.06% year-over-year to $163606.0 in Q4 2025; TTM through Dec 2025 was $163606.0, a 90.06% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 58.39% from the prior year.
• Treasury Shares for Q4 2025 stood at $163606.0, down from $1.6 million in the prior quarter.
• Over the last five years, Treasury Shares for RLAY reached as high as $1.6 million in Q4 2024 and fell as low as $163606.0 in Q4 2025.
• Historically, Treasury Shares has averaged $1.0 million across 4 years, with a median of $1.1 million in 2021.
• Across the five-year window, Treasury Shares jumped 718.1% in 2021 and tumbled 90.06% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $691205.0 in 2021, then jumped by 126.67% to $1.6 million in 2022, then increased by 5.06% to $1.6 million in 2024, then tumbled by 90.06% to $163606.0 in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $163606.0 in Q4 2025, $1.6 million in Q4 2024, and $1.6 million in Q4 2022.